catheterization

导管插入术
  • 文章类型: English Abstract
    A total of 309 (138 males and 171 females) end-stage renal disease patients who underwent implantation of early cannulation arteriovenous grafts (Acuseal) for hemodialysis in Nanfang Hospital, Southern Medical University between December 2016 and May 2021 were retrospectively included. The age of patients was (61.5±10.3) years. There were 244 patients (119 males and 125 females) who received regular follow-up. During the follow-up period, 24 patients died. Perioperative complications included graft infection (4.5%, 11/244), hematoma (4.5%, 11/244) and steal syndrome (4.1%, 10/244). No seroma or anastomotic rupture occurred. The rates of the first postoperative puncture time within 24 h, 48 h and 72 h after implantation were 42.2%(103/244), 32.4% (79/244) and 16.4% (40/244), respectively. The Kaplan-Meier survival analysis showed that the primary patency rates at 6 months and 12 months were 66.5% and 48.4%, respectively, and the secondary patency rates at 6 months and 12 months were 96.7% and 91.8%, respectively. The current study indicates that the Acuseal graft is safe for vascular access in patients requiring hemodialysis, with satisfactory patency and acceptable complication rates at 1-year follow-up.
    回顾性分析2016年12月至2021年5月在南方医科大学南方医院因血液透析植入即穿型人工血管构建动静脉移植物内瘘的309例终末期肾病患者(男138例,女171例)的临床资料。患者年龄(61.5±10.3)岁,其中244例患者(男119例,女125例)得到规律随访。随访期间24例患者死亡。309例患者中围手术期并发症包括移植物感染11例(4.5%),穿刺相关血肿11例(4.5%),窃血综合征10例(4.1%),无血清肿、吻合口破裂及移植物内瘘血栓形成发生。植入人工血管后24、48、72 h内进行第1次穿刺透析的比例分别为42.2%(103/244)、32.4%(79/244)、16.4%(40/244)。Kaplan-Meier生存分析结果显示,6、12个月初级通畅率分别为66.5%、48.4%,6、12个月次级通畅率分别为96.7%、91.8%。本研究结果显示即穿型人工血管移植物可安全地用于终末期肾病患者作为血管通路,其中12个月的随访结果满意。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    通过右颈内静脉(RIJV)将电极导管插入冠状窦(CS)会导致气胸和严重血肿形成。进行这项研究是为了比较通过左肘浅静脉与RIJV进行导管插入的安全性和可行性。
    这项前瞻性非随机研究涉及2021年9月至2023年2月连续接受导管消融的患者。左肘静脉组采用盲穿刺技术;RIJV组采用超声引导下插入。鞘管插入和CS导管插入的成功率,CS插管的程序和透视次数,比较两组并发症发生情况。
    左肘静脉组包括152名患者,RIJV组包括58例患者。肘静脉组的鞘插入成功率明显低于RIJV组(84.9%vs100%,分别为;p=.0008)。在肘静脉组,20例患者的盲穿刺尝试失败;3例患者发生导丝引起的静脉损伤.RIJV组发生1次动脉穿刺。成功插入护套后,CS插管成功率无显著差异(97%vs100%,p=.55),手术时间(中位数[范围],93[51-174]vs74[44-129]s;p=.19),或透视时间(中位数[范围],66[36-134]vs48[30-92]s;p=.17)。没有发生需要停止手术的严重并发症。
    左肘静脉入路是实用的,为RIJV方法提供可行的替代方案。
    UNASSIGNED: Insertion of electrode catheters into the coronary sinus (CS) through the right internal jugular vein (RIJV) carries risks of pneumothorax and severe hematoma formation. This study was performed to compare the safety and feasibility of catheterization through the left cubital superficial vein versus the RIJV.
    UNASSIGNED: This prospective nonrandomized study involved consecutive patients who underwent catheter ablation from September 2021 to February 2023. Blind puncture techniques were used in the left cubital vein group; ultrasound-guided insertion was performed in the RIJV group. The success rates of sheath insertion and CS catheterization, the procedure and fluoroscopy times of CS cannulation, and complications were compared between groups.
    UNASSIGNED: The left cubital vein group comprised 152 patients, and the RIJV group comprised 58 patients. The sheath insertion success rate was significantly lower in the cubital vein group than in the RIJV group (84.9% vs 100%, respectively; p = .0008). In the cubital vein group, blind puncture attempts failed in 20 patients; three patients developed guidewire-induced venous injury. One arterial puncture occurred in the RIJV group. After successful sheath insertion, no significant differences were observed in the CS cannulation success rate (97% vs 100%, p = .55), procedure time (median [range], 93 [51-174] vs 74 [44-129] s; p = .19), or fluoroscopy time (median [range], 66 [36-134] vs 48 [30-92] s; p = .17). No serious complications requiring procedural discontinuation occurred.
    UNASSIGNED: The left cubital vein approach is practical, offering a viable alternative to the RIJV approach.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    动脉导管未闭(PDA)的封堵器正在迅速发展,AmplatzerPiccolo封堵器(Abbott)获得美国食品和药物管理局的批准,并成为首个被批准用于≥700g患者的PDA封堵的装置。我们报告了早产儿在Piccolo封堵PDA后出现的首例完全左肺动脉(LPA)封堵的已知病例。
    PDA关闭的回顾性图表分析。
    在过去2年中,我们在早产新生儿中进行了50多例Piccolo装置封堵PDA,这2例代表我们唯一的并发症(4%)。这表示总并发症发生率与已发布此手术数据的大多数中心相似或更低。
    虽然罕见,在PDA封堵装置后,早产儿出现严重的LPA梗阻.Piccolo装置被设计为理想地完全保持在导管内。虽然我们的设备选择似乎提供了一个足够短的设备,对于给定的导管长度,我们建议,只要有可能,考虑使用尽可能短的设备。如果在任何时候影像学显示阻塞/湍流程度增加,我们还建议将超声心动图监测的频率增加到每周研究。
    UNASSIGNED: Device closure of a patent ductus arteriosus (PDA) is rapidly evolving, with the Amplatzer Piccolo Occluder (Abbott) receiving US Food and Drug Administration approval and becoming the first device approved for PDA closure in patients ≥700 g. We report on the first known cases of complete left pulmonary artery (LPA) occlusion following Piccolo closure of a PDA in premature infants.
    UNASSIGNED: Retrospective chart analysis of PDA closures.
    UNASSIGNED: We have performed over 50 cases of Piccolo device closure of the PDA in preterm neonates in the past 2 years, with these 2 cases representing our only complications (4%). This represents a total complication rate similar to or lower than most centers that have published data for this procedure.
    UNASSIGNED: Although rare, severe LPA obstruction can be seen in premature infants following device closure of the PDA. The Piccolo device is designed to ideally remain entirely intraductal. Although our device selection appeared to provide a device short enough for the given ductal length, we recommend, whenever possible, giving consideration to using the shortest possible device. We also recommend increasing the frequency of echocardiographic surveillance to weekly studies if at any time the imaging demonstrates an increase in the degree of obstruction/turbulence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    我们的目标是在OpSensOptoWireIII及其新的专有TAVR算法与导管插入术和超声心动图(经胸超声心动图和经食道超声心动图)得出的血液动力学值之间建立与经导管主动脉瓣置换术(TAVR)期间梯度测量相关的一致性程度。
    当前的研究是前瞻性的,单臂,单中心研究。所有受试者在TAVR之前和之后都进行了血液动力学评估,使用标准的血液动力学评估,使用2根辫子,经胸超声心动图,经食管超声心动图,和OpSensOptoWireIII。主要终点是OpSensOptoWireIII与导管插入术得出的血液动力学值之间的最终TAVR后平均梯度相关性。
    在2021年7月至2021年9月之间,招募了20名患者。中位年龄为79[6.5]岁,9(45%)患者为女性。通过2-pigtail技术得出的TAVR之前的平均梯度与使用OpSensOptoWireIII的平均梯度相似(35±14mmHgvs35±14mmHg,P=1.00),绝对平均差为2.2±3.5mmHg,具有很强的相关性(r=0.96,P<.0001)。在TAVR之后,2-pigtail技术得出的平均梯度和使用OpSensOptoWireIII的平均梯度相似(2.2±3.5vs2.8±2.7,P=.16),绝对平均差为1.2±1.3mmHg,具有很强的相关性(r=0.89,P<.0001)。
    由OpSensOptoWireIII导线及其新的TAVR算法得出的血液动力学评估与TAVR之前和之后的2根光纤得出的测量值具有极好的相关性。将这项新技术集成到具有实时血液动力学评估的专用TAVR线中,可以为TAVR操作员带来有意义的价值。
    UNASSIGNED: We aim to establish the degree of agreement related to gradient measurement during transcatheter aortic valve replacement (TAVR) between the OpSens OptoWire III and its new proprietary TAVR algorithm and hemodynamic value derived by catheterization and echocardiogram (transthoracic echocardiogram and transesophageal echocardiogram).
    UNASSIGNED: The current study was a prospective, single-arm, single-center study. All subjects underwent hemodynamic assessment before and after TAVR using standard hemodynamic assessment using 2 pigtails, transthoracic echocardiogram, transesophageal echocardiogram, and the OpSens OptoWire III. The primary end point was the final post-TAVR mean gradient correlation between OpSens OptoWire III and hemodynamic values derived by catheterization.
    UNASSIGNED: Between July 2021 and September 2021, 20 patients were enrolled. The median age was 79 [6.5] years, and 9 (45%) patients were female. The mean gradient before TAVR derived by 2-pigtail technique and the mean gradient using the OpSens OptoWire III were similar (35 ± 14 mm Hg vs 35 ± 14 mm Hg, P = 1.00), with an absolute mean difference of 2.2 ± 3.5 mm Hg and a strong correlation (r = 0.96, P < .0001). After TAVR, the mean gradient derived by 2-pigtail technique and the mean gradient using the OpSens OptoWire III were similar (2.2 ± 3.5 vs 2.8 ± 2.7, P = .16), with an absolute mean difference of 1.2 ± 1.3 mm Hg and a strong correlation (r = 0.89, P < .0001).
    UNASSIGNED: Hemodynamic assessment derived by the OpSens OptoWire III wire and its new TAVR algorithm demonstrated excellent correlation with measurements derived by 2 pigtails both before and after TAVR. Integration of this new technology within a dedicated TAVR wire with live hemodynamic assessment could bring meaningful value to TAVR operators.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:脑灌注可能根据动脉插管部位而变化,并可能影响心脏切开术后体外生命支持(ECLS)中神经系统不良事件的发生率。当前的研究将患者的神经系统结局与三种常用的动脉插管策略进行了比较(主动脉与锁骨下/腋窝vs.股动脉),以评估每种ECLS配置是否与神经系统并发症的不同发生率相关。
    方法:本回顾性研究,多中心(34个中心),观察性研究纳入了2000年1月至2020年12月期间需要进行心脏切开术后ECLS的成年人,该研究出现在心脏切开术后体外生命支持(PELS)研究数据库中.主动脉患者,比较锁骨下/腋下和股骨插管在复合神经系统终点(缺血性卒中,脑出血,脑水肿)。次要结局是总体住院死亡率,神经系统并发症是院内死亡的原因,和术后轻微的神经系统并发症(癫痫发作)。通过线性混合效应模型研究了插管与神经系统结局之间的关联。
    结果:这项研究包括1897名患者,其中主动脉占26.5%(n=503),20.9%锁骨下/腋下(n=397)和52.6%股骨(n=997)插管。锁骨下/腋下组的高血压病史更为频繁,吸烟,糖尿病,以前的心肌梗塞,透析,外周动脉疾病和既往卒中。神经监测在所有组中都很少使用。在混合效应模型调整后,锁骨下/腋下的主要神经系统并发症更为常见(主动脉:n=79,15.8%;锁骨下/腋下:n=78,19.6%;股骨:n=118,11.9%;p<0.001)(OR1.53[95%CI1.02-2.31],p=0.041)。癫痫发作在锁骨下/腋下(n=13,3.4%)比主动脉(n=9,1.8%)和股骨插管(n=12,1.3%,p=0.036)。主动脉插管后住院死亡率更高(主动脉:n=344,68.4%,锁骨下/腋下:n=223,56.2%,股骨:n=587,58.9%,p<0.001),如Kaplan-Meier曲线所示。总之,神经系统死亡原因(主动脉:n=12,3.9%,锁骨下/腋下:n=14,6.6%,股骨:n=28,5.0%,p=0.433)相似。
    结论:在PELS研究的分析中,锁骨下/腋下插管与较高的主要神经系统并发症和癫痫发作率相关。主动脉插管后住院死亡率较高,尽管这些患者的神经系统死亡原因发生率没有显着差异。这些结果鼓励对ECLS患者的神经系统并发症和神经监测使用保持警惕,尤其是锁骨下/腋下插管。
    BACKGROUND: Cerebral perfusion may change depending on arterial cannulation site and may affect the incidence of neurologic adverse events in post-cardiotomy extracorporeal life support (ECLS). The current study compares patients\' neurologic outcomes with three commonly used arterial cannulation strategies (aortic vs. subclavian/axillary vs. femoral artery) to evaluate if each ECLS configuration is associated with different rates of neurologic complications.
    METHODS: This retrospective, multicenter (34 centers), observational study included adults requiring post-cardiotomy ECLS between January 2000 and December 2020 present in the Post-Cardiotomy Extracorporeal Life Support (PELS) Study database. Patients with Aortic, Subclavian/Axillary and Femoral cannulation were compared on the incidence of a composite neurological end-point (ischemic stroke, cerebral hemorrhage, brain edema). Secondary outcomes were overall in-hospital mortality, neurologic complications as cause of in-hospital death, and post-operative minor neurologic complications (seizures). Association between cannulation and neurological outcomes were investigated through linear mixed-effects models.
    RESULTS: This study included 1897 patients comprising 26.5% Aortic (n = 503), 20.9% Subclavian/Axillary (n = 397) and 52.6% Femoral (n = 997) cannulations. The Subclavian/Axillary group featured a more frequent history of hypertension, smoking, diabetes, previous myocardial infarction, dialysis, peripheral artery disease and previous stroke. Neuro-monitoring was used infrequently in all groups. Major neurologic complications were more frequent in Subclavian/Axillary (Aortic: n = 79, 15.8%; Subclavian/Axillary: n = 78, 19.6%; Femoral: n = 118, 11.9%; p < 0.001) also after mixed-effects model adjustment (OR 1.53 [95% CI 1.02-2.31], p = 0.041). Seizures were more common in Subclavian/Axillary (n = 13, 3.4%) than Aortic (n = 9, 1.8%) and Femoral cannulation (n = 12, 1.3%, p = 0.036). In-hospital mortality was higher after Aortic cannulation (Aortic: n = 344, 68.4%, Subclavian/Axillary: n = 223, 56.2%, Femoral: n = 587, 58.9%, p < 0.001), as shown by Kaplan-Meier curves. Anyhow, neurologic cause of death (Aortic: n = 12, 3.9%, Subclavian/Axillary: n = 14, 6.6%, Femoral: n = 28, 5.0%, p = 0.433) was similar.
    CONCLUSIONS: In this analysis of the PELS Study, Subclavian/Axillary cannulation was associated with higher rates of major neurologic complications and seizures. In-hospital mortality was higher after Aortic cannulation, despite no significant differences in incidence of neurological cause of death in these patients. These results encourage vigilance for neurologic complications and neuromonitoring use in patients on ECLS, especially with Subclavian/Axillary cannulation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:间歇性导尿管(IC)常用于膀胱管理,但导尿管相关尿路感染(CAUTIs)仍然具有挑战性。插入尖端可以通过最小化沿泌尿道的细菌转移来降低CAUTI的风险。然而,很少有实验室测试来评估这种技术。我们描述了使用适应的体外尿道琼脂模型来评估IC的细菌置换。
    结果:模拟尿道琼脂通道(UAC)是在对攻击生物具有特异性的选择性培养基中用导管特异性大小的通道制备的。在插入IC之前用大肠杆菌和粪肠杆菌接种UAC,并且在插入之后进行UAC切片的计数。评估了四个IC:CureCatheter®封闭系统(CCS),VaProPlusPocketTM,Bard®Touchless®Plus,和SpeediCath®Flex套装。与其他IC相比,CCS显示出沿着UAC的细菌位移显着降低,并且也是唯一在UAC末端(代表近端尿道)具有无法检测到的细菌水平的IC。
    结论:细菌置换试验表明,具有插入尖端的测试IC之间的细菌转移存在显着差异,这可能反映了它们的不同设计。该方法可用于评估CAUTI预防技术,并有助于指导未来的技术创新。
    OBJECTIVE: Intermittent catheters (ICs) are commonly used in bladder management but catheter-associated urinary tract infections (CAUTIs) remain challenging. Insertion tips may reduce the risk of CAUTIs by minimizing bacterial transfer along the urinary tract. However, there are few laboratory tests to evaluate such technologies. We describe the use of an adapted in vitro urethra agar model to assess bacterial displacement by ICs.
    RESULTS: Simulated urethra agar channels (UACs) were prepared with catheter-specific sized channels in selective media specific to the challenge organisms. UACs were inoculated with E. coli and E. faecalis before insertion of ICs and enumeration of UAC sections were performed following insertion. Four ICs were evaluated: Cure Catheter® Closed System (CCS), VaPro Plus PocketTM, Bard® Touchless® Plus, and SpeediCath® Flex Set. CCS demonstrated significantly reduced bacterial displacement along the UACs compared to the other ICs and was also the only IC with undetectable levels of bacteria towards the end of the UAC (representing the proximal urethra).
    CONCLUSIONS: The bacterial displacement test demonstrated significant differences in bacterial transfer between the test ICs with insertion tips which may reflect their different designs. This method is useful for evaluating CAUTI prevention technology and may help guide future technology innovations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    中国大约有200万成人先天性心脏病患者,中度和重度患者的数量正在增加。然而,很少有研究调查导管插入后严重不良事件(SAE)的风险.这项研究的目的是确定与心导管插入相关的SAE的危险因素,并提供预测SAE的风险评分模型。
    回顾性收集2018年1月至2022年1月在武汉科技大学附属武汉亚洲心脏医院行心导管插入术的中重度成人先天性心脏病(ACHD)患者690例,随后分为建模组和验证组。对已识别的SAE危险因素进行了单变量分析,然后将显著因素纳入多因素logistic回归模型以筛选SAE的独立预测因子.受试者工作特性曲线(ROC)和Hosmer-Lemeshow试验用于评估模型的鉴别和校准,分别。
    符合纳入标准的690例导管插入手术中有69例(10.0%)发生SAE。建立的SAE风险计算公式为logit(p)=-6.1340.992×肺动脉高压(是)+1.459×疾病严重程度(严重)+2.324×手术类型(诊断和介入)+1.436×cTnI(≥0.028μg/L)+1.537×NT-proBNP(≥126.65pg/mL)。基于各预测因子效应大小的最终风险评分模型总分为0~7分,涉及肺动脉高压(1分),疾病严重程度(1分),程序类型(2分),cTnI(1分)和NT-proBNP(2分),得分大于3表示高风险。推导和验证队列的ROC曲线下面积的C统计量为0.840和0.911,分别。根据Hosmer-Lemeshow测试,模型组和验证组的p值分别为0.064和0.868.
    本研究建立的风险预测模型具有很高的辨别力和校准性,可为临床预测和评估中重度ACHD患者心导管术后SAE风险提供参考。
    UNASSIGNED: There are almost 2 million adult patients with congenital heart disease in China, and the number of moderate and severe patients is increasing. However, few studies have investigated the risk of serious adverse events (SAE) after catheterization among them. The aim of this study was to identify risk factors for SAE related to cardiac catheterization and to provide the risk scoring model for predicting SAE.
    UNASSIGNED: A total of 690 patients with moderate and severe adult patients with congenital heart disease (ACHD) who underwent cardiac catheterization in Wuhan Asian Heart Hospital Affiliated to Wuhan University of Science and Technology from January 2018 to January 2022 were retrospectively collected and subsequently divided into a modeling group and a verification group. A univariate analysis was performed on the identified SAE risk factors, and then significant factors were included in the multivariate logistic regression model to screen for independent predictors of SAE. The receiver operating characteristic curve (ROC) and the Hosmer-Lemeshow test were used to evaluate the discrimination and calibration of the model, respectively.
    UNASSIGNED: A SAE occurred in 69 (10.0%) of the 690 catheterization procedures meeting inclusion criteria. The established SAE risk calculation formula was logit(p) = -6.134 + 0.992 × pulmonary artery hypertension (yes) + 1.459 × disease severity (severe) + 2.324 × procedure type (diagnostic and interventional) + 1.436 × cTnI ( ≥ 0.028 μ g/L) + 1.537 × NT-proBNP ( ≥ 126.65 pg/mL). The total score of the final risk score model based on the effect size of each predictor was 0 to 7, involving pulmonary artery hypertension (1 point), disease severity (1 point), procedure type (2 points), cTnI (1 point) and NT-proBNP (2 points), and the score greater than 3 means high risk. The C-statistic of the area under the ROC curve was 0.840 and 0.911 for the derivation and validation cohorts, respectively. According to the Hosmer-Lemeshow test, the p values in the modeling group and the verification group were 0.064 and 0.868, respectively.
    UNASSIGNED: The risk prediction model developed in this study has high discrimination and calibration, which can provide reference for clinical prediction and evaluation of SAE risk after cardiac catheterization in patients with moderate and severe ACHD.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在使用患者特征和导管插入技术特征变量来训练相应的机器学习(ML)模型,以预测外周中心静脉导管-深静脉血栓形成(PICCs-DVT),并从“输入-输出”相关性方面分析这两种特征对PICCs-DVT的重要性。全面系统地总结用于描述患者特征和导管插入技术特征的变量,本研究结合了18篇涉及预测PICCs-DVT的两种特征的文献.总结了用于描述这两种类型特征的总共21个变量,和特征值从2021年1月1日至2022年8月31日的1,065名PICCs患者数据中提取,构建数据样本集。然后,70%的样本集用于模型训练和超参数优化,并将30%的样本集用于三种常见ML分类模型(即支持向量分类器[SVC]、随机森林[RF],和人工神经网络[ANN])。在预测性能方面,本研究选择了四个指标来评估模型的预测性能:精度(P),召回(R),精度(ACC),和曲线下面积(AUC)。在特征重要性分析方面,本研究选择了一种基于“输入-输出”灵敏度原理-排列重要性的单一特征分析方法。对于平均模型性能,测试集上的三个ML模型分别为P=0.92、R=0.95、ACC=0.88和AUC=0.81。具体来说,RF模型为P=0.95,R=0.96,ACC=0.92,AUC=0.86;ANN模型为P=0.92,R=0.95,ACC=0.88,AUC=0.81;SVC模型为P=0.88,R=0.94,ACC=0.85,AUC=0.77。对于特征重要性分析,导管至静脉率(RF:91.55%,ANN:82.25%,SVC:87.71%),Zubrod-ECOG-WHO评分(RF:66.35%,ANN:82.25%,SVC:44.35%),和插入尝试(射频:44.35%,ANN:37.65%,SVC:65.80%)在PICCs-DVT的ML模型预测任务中均占据前三名,显示出相对一致的排名结果。ML模型在预测PICC-DVT方面表现出良好的性能,并从数据中揭示了特征重要性的相对一致的排名。揭示的重要特征可能有助于临床医务人员从数据驱动的角度更好地理解和分析PICC-DVT的形成机制。
    This study aims to use patient feature and catheterization technology feature variables to train the corresponding machine learning (ML) models to predict peripherally inserted central catheters-deep vein thrombosis (PICCs-DVT) and analyze the importance of the two types of features to PICCs-DVT from the aspect of \"input-output\" correlation. To comprehensively and systematically summarize the variables used to describe patient features and catheterization technical features, this study combined 18 literature involving the two types of features in predicting PICCs-DVT. A total of 21 variables used to describe the two types of features were summarized, and feature values were extracted from the data of 1,065 PICCs patients from January 1, 2021 to August 31, 2022, to construct a data sample set. Then, 70% of the sample set is used for model training and hyperparameter optimization, and 30% of the sample set is used for PICCs-DVT prediction and feature importance analysis of three common ML classification models (i.e. support vector classifier [SVC], random forest [RF], and artificial neural network [ANN]). In terms of prediction performance, this study selected four metrics to evaluate the prediction performance of the model: precision (P), recall (R), accuracy (ACC), and area under the curve (AUC). In terms of feature importance analysis, this study chooses a single feature analysis method based on the \"input-output\" sensitivity principle-Permutation Importance. For the mean model performance, the three ML models on the test set are P = 0.92, R = 0.95, ACC = 0.88, and AUC = 0.81. Specifically, the RF model is P = 0.95, R = 0.96, ACC = 0.92, AUC = 0.86; the ANN model is P = 0.92, R = 0.95, ACC = 0.88, AUC = 0.81; the SVC model is P = 0.88, R = 0.94, ACC = 0.85, AUC = 0.77. For feature importance analysis, Catheter-to-vein rate (RF: 91.55%, ANN: 82.25%, SVC: 87.71%), Zubrod-ECOG-WHO score (RF: 66.35%, ANN: 82.25%, SVC: 44.35%), and insertion attempt (RF: 44.35%, ANN: 37.65%, SVC: 65.80%) all occupy the top three in the ML models prediction task of PICCs-DVT, showing relatively consistent ranking results. The ML models show good performance in predicting PICCs-DVT and reveal a relatively consistent ranking of feature importance from the data. The important features revealed might help clinical medical staff to better understand and analyze the formation mechanism of PICCs-DVT from a data-driven perspective.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:Chiari网络,胎儿解剖结构的残余部分,由右心房内的网状结构组成。随着心脏干预的进步,与Chiari网络相关的并发症的报道越来越多.然而,在插入透析导管时,很少有关于Chiari网络中导丝或导管截留的报道.
    方法:一名患有终末期肾病的46岁男性住院,并接受了数字减影血管造影辅助的右颈内静脉隧道袖套透析导管插入术。当导丝进入约20厘米的深度时,很难推进,表现为扭转导丝时的阻力和无法进入下腔静脉。插入可剥离鞘后,很难拔出导丝。反复尝试旋转导丝后,导丝终于被拔出。纤维组织缠绕在导丝的尖端周围。它的长度是6厘米,具有光滑的表面和坚韧的纹理。我们认为我们取出的组织很可能是Chiari网络的一部分。
    结论:这个案例突出了Chiari网络使外科手术复杂化的可能性,包括导丝和导管操作困难。应该注意Chiari网络。超声心动图可用于识别Chiari网络。在手术过程中,不建议强行拉出卡住的导丝,以避免撕裂心房壁和引起心包填塞的风险。在这种情况下,与超声医生和心脏外科医生的紧急咨询可能会有所帮助。
    BACKGROUND: The Chiari network, a remnant of fetal anatomy, consists of a mesh-like structure within the right atrium. With advancements in cardiac interventions, complications associated with the Chiari network have increasingly been reported. However, there are few reports about guidewire or catheter entrapment in the Chiari network during the insertion of a dialysis catheter.
    METHODS: A 46-year-old male with end-stage renal disease was hospitalized and underwent a digital subtraction angiography-assisted catheterization of the right internal jugular vein tunnel-cuffed dialysis catheter. When the guide wire entered a depth of about 20 cm, it was difficult to advance, manifested as resistance when twisting the guide wire and inability to enter the inferior vena cava. After the peelable sheath was inserted, it was difficult to pull out the guide wire. After repeated attempts to rotate the guide wire, the guide wire was finally pulled out. A fibrous tissue was wrapped around the tip of the guide wire. Its length was 6 cm, with a smooth surface and tough texture. We considered that the tissue we pulled out was most likely a part of a Chiari network.
    CONCLUSIONS: This case highlights the potential for the Chiari network to complicate surgical procedures, including difficulty with guidewire and catheter manipulation. Attention should be paid to Chiari networks. Echocardiography can be used to identify the Chiari network. During the surgery, forcefully pulling out a stuck guidewire is not suggested, to avoid the risk of tearing the atrial wall and causing pericardial tamponade. An urgent consultation with ultrasound doctors and cardiac surgeons might be helpful in such cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    冠状动脉异常(ANOCOR)是具有各种解剖形式的先天性异常。在某些情况下可以提供经皮治疗,最常见的是解决相关的动脉粥样硬化疾病或,很少,来矫正先天性狭窄.由于导管插入的频繁困难,经皮冠状动脉介入治疗ANOCOR被认为是复杂的手术.彻底的解剖学理解有助于在冠状动脉造影期间识别连接部位和ANOCOR的初始异位过程。选择合适的导管是手术中的关键步骤。与其他异位病程相比,沿主动脉后路的动脉粥样硬化疾病的患病率更高。当治疗异位病程下游的动脉粥样硬化狭窄时,通常用于复杂冠状动脉手术的技术可能会有所帮助。虽然先天性狭窄的血管成形术在技术上是可行的,它在管理算法中的作用还有待定义。目前,对于35岁以上且有缺血症状或心肌缺血的成人,动脉间病程的右侧ANOCOR可采用这种类型的经皮治疗.
    Coronary artery anomalies (ANOCOR) are congenital anomalies with various anatomical forms. Percutaneous treatment can be offered in certain situations, most often to address associated atherosclerotic disease or, more rarely, to correct a congenital stenosis. Due to the frequent difficulties of catheterization, percutaneous coronary interventions for ANOCOR are recognized as complex procedures. A thorough anatomical understanding facilitates the identification of the connection site and the initial ectopic course of an ANOCOR during coronary angiography. Selecting an appropriate catheter is a crucial step in the procedure. There is a higher prevalence of atherosclerotic disease along retroaortic courses compared to other ectopic courses. When treating atherosclerotic stenosis downstream of an ectopic course, techniques typically used for complex coronary procedures can be helpful. While angioplasty for congenital stenosis is technically feasible, its role in management algorithms remains to be defined. Currently, this type of percutaneous treatment may be offered to right ANOCOR with interarterial course in adults over 35 years old and with ischemic symptoms or myocardial ischemia.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号